auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
80 |
4. Check minimum number of eventsNone |
80 |
5. Include endpointsNone |
80 |
6. Filter based on genotype QC (FinnGen only) |
80 |
Control definitions (FinnGen only)
- Control exclude
- H8_EXTERNAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H61
- Name in latin
- Morbositates non infectiosae auriculae
Similar endpoints
↥List of similar endpoints to
Noninfective disorders of pinna
based on the number of shared cases.
Similar with more cases:
- Diseases of external ear
- Diseases of the ear and mastoid process
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 684 | 319 | 359 |
| Only index persons | 610 | 287 | 323 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 32.55 | 34.65 | 30.36 |
| Only index persons | 32.98 | 37.05 | 29.37 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 80 | 45 | 35 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 50.23 | 46.07 | 55.57 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 70
- Matched controls
- 698
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H61.1
ICD-10 Finland
Noninfective disorders of pinna
+∞
80.5
61
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
14.2
7.4
12
10
3803B
ICD-9 Finland
Disorders of external ear, Non-infectious disorders of pinna[DEFORMATIO AURICULARIS AQCUISITA]
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
21
66
3.96
6.12
1.7
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
19
71
3.20
4.19
1.2
1.4
titre
173.3
461.2
—
6
17
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
16
62
2.98
3.28
1.9
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
59
2.90
2.99
1.9
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
6
12
5.31
2.45
1.2
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
25
142
2.11
2.27
2.5
1.3
g/l
2.0
2.3
0.74
19
82
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
18
90
2.29
2.22
2.0
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
26
155
2.00
2.06
1.3
1.2
u/ml
8.4
0.9
—
8
44
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
33
2.94
2.00
2.1
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
12
4.37
1.85
1.0
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
19
3.33
1.69
1.2
1.2
u/l
5.6
5.9
—
6
14
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
25
2.97
1.69
1.0
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
42
314
1.71
1.54
5.2
5.5
e9/l
1.8
1.8
0.09
37
284
(42870588) Differential panel, method unspecified - Blood
28
189
1.74
1.46
5.4
5.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
40
299
1.68
1.44
5.3
5.6
e9/l
0.5
0.6
0.11
33
264
(3006315) Basophils [#/volume] in Blood
40
299
1.68
1.44
5.3
5.7
e9/l
0.0
0.0
0.22
33
267
(3013115) Eosinophils [#/volume] in Blood
41
310
1.66
1.40
5.2
5.9
e9/l
0.2
0.2
0.13
35
280
(3013650) Neutrophils [#/volume] in Blood by Automated count
45
349
1.66
1.39
6.7
10.3
e9/l
4.5
3.9
0.69
38
316
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
59
496
1.72
1.30
3.8
4.0
pmol/l
14.5
14.9
0.58
50
456
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
23
152
1.72
1.28
1.7
3.7
ng/l
633.9
966.6
0.68
18
129
(3004588) Protein electrophoresis panel - Serum or Plasma
6
26
2.41
1.21
3.3
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
54
453
1.59
1.10
3.1
3.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
38
295
1.55
1.09
9.3
8.4
e9/l
0.0
0.0
0.50
27
244
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
37
1.98
0.96
1.3
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
28
2.23
0.94
4.7
6.4
mmol/l
23.8
24.0
—
6
28
(3013707) Erythrocyte sedimentation rate by Westergren method
54
464
1.50
0.90
3.9
4.0
mm/h
15.6
11.1
0.83
49
439
(40768443) Skin Pathology biopsy report
6
30
2.08
0.89
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
66
595
1.62
0.85
15.6
13.4
%
40.6
40.5
0.06
50
475
(40768793) Breast Pathology biopsy report
0
25
0.00
0.80
0.0
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
29
226
1.44
0.77
12.5
6.7
inr
1.2
1.2
—
9
77
(3023368) Bacteria identified in Blood by Culture
21
154
1.49
0.75
5.2
3.8
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
5
26
1.98
0.72
3.0
1.8
nmol/l
24.8
41.1
—
5
26
(3014007) Fractional oxyhemoglobin in Arterial blood
5
29
1.77
0.65
6.2
10.9
%
93.3
94.3
—
5
29
(3041096) Erythrocytes [Presence] in Urine by Automated
13
182
0.66
0.63
2.2
2.9
—
—
—
0
0
(3002256) Pathology report gross observation
11
72
1.61
0.63
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
52
1.60
0.62
1.4
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
52
1.60
0.62
2.1
2.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
20
0.00
0.61
0.0
2.4
—
3.4
—
0
12
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
29
235
1.37
0.60
4.4
2.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
54
1.53
0.59
3.1
3.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
23
0.00
0.59
0.0
4.7
—
34.9
—
0
14
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
71
665
1.60
0.58
15.2
12.7
mg/l
28.3
20.2
0.80
55
521
(3044889) 12 lead EKG panel
48
423
1.34
0.57
3.8
3.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
83
1.52
0.55
1.8
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
62
1.51
0.55
1.9
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
39
1.58
0.54
1.0
1.3
—
—
—
0
0
(4010399)
6
39
1.58
0.54
1.0
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
29
239
1.33
0.53
2.4
2.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
187
0.70
0.53
2.7
2.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
10
67
1.56
0.52
1.6
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
19
239
0.73
0.51
3.6
3.7
ng/l
24.5
32.6
0.30
13
158
(3018095) Leukocytes [#/volume] in Urine
30
250
1.32
0.51
3.2
3.1
e6/l
16.6
53.8
1.05
20
179
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
148
1.37
0.49
2.3
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
20
247
0.75
0.47
2.6
3.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
57
1.45
0.44
2.5
2.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
2.3
—
0.3
—
0
10
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
3.5
—
55.8
—
0
17
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
62.9
—
0
18
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
28
240
1.26
0.37
2.5
1.8
pmol/l
100.9
98.3
0.11
13
124
(3031040) Bacteria [#/volume] in Urine by Automated count
48
439
1.23
0.35
4.2
4.0
—
62.8
—
0
10
(3000991) Gas panel - Venous blood
6
45
1.36
0.34
4.3
7.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
45
1.36
0.34
1.3
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
46
1.33
0.34
1.8
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
46
1.33
0.34
1.0
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
16
130
1.29
0.32
1.9
1.7
mg/l
1.3
1.3
—
10
108
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
58
613
0.80
0.31
4.4
3.6
mmol/l
1.3
1.3
0.15
52
568
(40758558) Short blood count panel - Blood
20
169
1.24
0.29
6.8
6.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
31
275
1.21
0.29
8.9
6.1
mmol/l
1.2
1.2
0.10
26
235
(3022145) Colonoscopy Study observation
9
71
1.30
0.27
1.0
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
133
1.25
0.27
2.5
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
9
76
1.21
0.26
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
14
115
1.26
0.25
1.7
1.7
nmol/l
926.3
1233.8
—
9
91
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
84
0.69
0.25
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
15
178
0.81
0.25
8.0
3.4
mg/mmol
5.1
10.6
—
9
100
(40761535) Cells panel - Urine sediment
5
37
1.37
0.24
6.0
3.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
79
1.30
0.23
2.0
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
64
613
1.22
0.23
15.7
11.9
ml/min/173m2
84.2
85.2
0.11
52
494
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
89
1.27
0.22
2.5
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
24
213
1.18
0.22
3.3
2.6
e6/l
17.5
30.8
0.49
18
165
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.5
—
3.2
—
0
11
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
2.2
—
97.0
—
0
6
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
21
237
0.85
0.21
3.0
2.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
12
0.00
0.21
0.0
5.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
3.1
—
1.6
—
0
12
(3038515) Glucose [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
3.1
—
7.2
—
0
12
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
5.2
—
137.7
—
0
12
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
47
1.30
0.21
2.0
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
156
1.20
0.21
2.1
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
22
195
1.18
0.20
3.0
2.3
—
—
—
0
0
(3000492) Spirometry study
7
57
1.25
0.19
1.1
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
59
1.20
0.18
4.9
9.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
16
139
1.19
0.18
3.8
4.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
14
120
1.20
0.18
1.8
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
64
618
1.18
0.17
4.8
4.2
mmol/l
6.0
5.8
0.37
59
576
(3003694) ABO and Rh group [Type] in Blood
17
189
0.87
0.13
1.4
1.5
—
—
—
0
0
(3013512) EKG study
17
153
1.14
0.12
3.6
3.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
32
301
1.11
0.12
3.5
3.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
70
685
1.18
0.11
13.8
11.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
21
193
1.12
0.11
2.6
2.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
21
194
1.11
0.10
3.1
2.4
e6/l
0.6
0.3
0.26
15
147
(3003396) Base excess in Arterial blood by calculation
6
57
1.06
0.09
5.3
6.6
mmol/l
0.2
0.4
—
6
40
(4035726)
6
58
1.04
0.08
1.5
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
68
1.03
0.08
2.4
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
100
1.12
0.05
2.6
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
46
450
1.05
0.03
4.7
4.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
33
321
1.05
0.03
2.4
3.3
estimate
0.0
0.0
—
7
74
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
15
142
1.07
0.02
1.4
1.6
pmol/l
455.1
437.7
—
10
124
(3021601) Nitrite [Presence] in Urine by Test strip
33
323
1.04
0.01
2.9
4.4
estimate
0.0
0.0
—
7
74
(3019150) Specific gravity of Urine by Refractometry
14
134
1.05
0.00
2.4
3.5
—
1.0
—
0
19
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
63
636
0.96
0.00
4.8
4.1
mmol/l
4.5
4.7
0.87
56
592
(3009261) Glucose [Presence] in Urine by Test strip
33
327
1.02
0.00
2.4
3.3
estimate
0.0
0.0
—
7
69
(3029937) Albumin [Presence] in Urine by Test strip
17
175
0.96
0.00
3.1
3.6
estimate
0.0
0.0
—
6
72
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
136
1.04
0.00
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
125
1.05
0.00
1.4
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
65
646
1.03
0.00
4.9
4.5
mmol/l
2.6
2.8
0.70
60
602
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
63
634
0.97
0.00
4.7
4.0
mmol/l
1.4
1.5
0.64
57
589
(3035285) Chloride [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
3.3
—
106.6
—
0
8
(21494815) CD4 cells/100 lymphocytes in Specimen
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
239.3
—
0
7
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.1
—
10.8
—
0
7
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
75.5
—
0
6
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
3.3
—
4.0
—
0
8
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
6.6
—
0
5
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3012544) pH of Venous blood
5
50
1.00
0.00
2.8
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
9
0.00
0.00
0.0
2.0
—
67.0
—
0
9
(3019832) Treponema pallidum Ab [Presence] in Serum
9
89
1.01
0.00
1.7
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_PINNADIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have H8_PINNADIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: H8_PINNADIS – Noninfective disorders of pinna
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data